FAST-A Study to evaluate the Efficacy and Safety of Quetiapin IR in Patients with acute Psychosis - FAST

Study identifier:D1443L00009

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Terminated/Withdrawn

Official Title

-

Medical condition

Psychotic Disorders

Phase

Phase 3

Healthy volunteers

No

Study drug

Quetiapine

Sex

All

Actual Enrollment

-

Study type

Interventional

Age

18 Years - 65 Years

Date

Study Start Date: 01 May 2007
Primary Completion Date: 01 Aug 2007
Study Completion Date: 01 Aug 2007

Study design

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria